Phenotypic and Genetic Evolutions of a Porcine Reproductive and Respiratory Syndrome Modified Live Vaccine after Limited Passages in Pigs

Modified live vaccines (MLVs) against the porcine reproductive and respiratory syndrome virus (PRRSV) have been regularly associated with safety issues, such as reversion to virulence. In order to characterize the phenotypic and genetic evolution of the PRRSV-1 DV strain from the Porcilis<sup>...

Full description

Bibliographic Details
Main Authors: Julie Eclercy, Patricia Renson, Edouard Hirchaud, Mathieu Andraud, Véronique Beven, Frédéric Paboeuf, Nicolas Rose, Yannick Blanchard, Olivier Bourry
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/9/4/392
id doaj-1aed5ddf6542418b92973abec756cf37
record_format Article
spelling doaj-1aed5ddf6542418b92973abec756cf372021-04-16T23:01:27ZengMDPI AGVaccines2076-393X2021-04-01939239210.3390/vaccines9040392Phenotypic and Genetic Evolutions of a Porcine Reproductive and Respiratory Syndrome Modified Live Vaccine after Limited Passages in PigsJulie Eclercy0Patricia Renson1Edouard Hirchaud2Mathieu Andraud3Véronique Beven4Frédéric Paboeuf5Nicolas Rose6Yannick Blanchard7Olivier Bourry8Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail (Anses), Laboratoire de Ploufragan-Plouzané-Niort, BP 53, 22440 Ploufragan, FranceAgence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail (Anses), Laboratoire de Ploufragan-Plouzané-Niort, BP 53, 22440 Ploufragan, FranceAgence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail (Anses), Laboratoire de Ploufragan-Plouzané-Niort, BP 53, 22440 Ploufragan, FranceAgence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail (Anses), Laboratoire de Ploufragan-Plouzané-Niort, BP 53, 22440 Ploufragan, FranceAgence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail (Anses), Laboratoire de Ploufragan-Plouzané-Niort, BP 53, 22440 Ploufragan, FranceAgence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail (Anses), Laboratoire de Ploufragan-Plouzané-Niort, BP 53, 22440 Ploufragan, FranceAgence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail (Anses), Laboratoire de Ploufragan-Plouzané-Niort, BP 53, 22440 Ploufragan, FranceAgence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail (Anses), Laboratoire de Ploufragan-Plouzané-Niort, BP 53, 22440 Ploufragan, FranceAgence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail (Anses), Laboratoire de Ploufragan-Plouzané-Niort, BP 53, 22440 Ploufragan, FranceModified live vaccines (MLVs) against the porcine reproductive and respiratory syndrome virus (PRRSV) have been regularly associated with safety issues, such as reversion to virulence. In order to characterize the phenotypic and genetic evolution of the PRRSV-1 DV strain from the Porcilis<sup>®</sup> PRRS MLV after limited passages in pigs, three in vivo experiments were performed. Trial#1 aimed (i) at studying transmission of the vaccine strain from vaccinated to unvaccinated contact pigs. Trial#2 and Trial#3 were designed (ii) to assess the reproducibility of Trial#1, using another vaccine batch, and (iii) to compare the virulence levels of two DV strains isolated from vaccinated (passage one) and diseased contact pigs (passage two) from Trial#1. DV strain isolates from vaccinated and contact pigs from Trial#1 and Trial#2 were submitted to Next-Generation Sequencing (NGS) full-genome sequencing. All contact animals from Trial#1 were infected and showed significantly increased viremia compared to vaccinated pigs, whereas no such change was observed during Trial#2. In Trial#3, viremia and transmission were higher for inoculated pigs with passage two of the DV strain, compared with passage one. In this study, we showed that the re-adaptation of the DV strain to pigs is associated with faster replication and increased transmission of the vaccine strain. Punctually, a decrease of attenuation of the DV vaccine strain associated with clinical signs and increased viremia may occur after limited passages in pigs. Furthermore, we identified three mutations linked to pig re-adaptation and five other mutations as potential virulence determinants.https://www.mdpi.com/2076-393X/9/4/392PRRS virusmodified live vaccineattenuationvariantsmutation
collection DOAJ
language English
format Article
sources DOAJ
author Julie Eclercy
Patricia Renson
Edouard Hirchaud
Mathieu Andraud
Véronique Beven
Frédéric Paboeuf
Nicolas Rose
Yannick Blanchard
Olivier Bourry
spellingShingle Julie Eclercy
Patricia Renson
Edouard Hirchaud
Mathieu Andraud
Véronique Beven
Frédéric Paboeuf
Nicolas Rose
Yannick Blanchard
Olivier Bourry
Phenotypic and Genetic Evolutions of a Porcine Reproductive and Respiratory Syndrome Modified Live Vaccine after Limited Passages in Pigs
Vaccines
PRRS virus
modified live vaccine
attenuation
variants
mutation
author_facet Julie Eclercy
Patricia Renson
Edouard Hirchaud
Mathieu Andraud
Véronique Beven
Frédéric Paboeuf
Nicolas Rose
Yannick Blanchard
Olivier Bourry
author_sort Julie Eclercy
title Phenotypic and Genetic Evolutions of a Porcine Reproductive and Respiratory Syndrome Modified Live Vaccine after Limited Passages in Pigs
title_short Phenotypic and Genetic Evolutions of a Porcine Reproductive and Respiratory Syndrome Modified Live Vaccine after Limited Passages in Pigs
title_full Phenotypic and Genetic Evolutions of a Porcine Reproductive and Respiratory Syndrome Modified Live Vaccine after Limited Passages in Pigs
title_fullStr Phenotypic and Genetic Evolutions of a Porcine Reproductive and Respiratory Syndrome Modified Live Vaccine after Limited Passages in Pigs
title_full_unstemmed Phenotypic and Genetic Evolutions of a Porcine Reproductive and Respiratory Syndrome Modified Live Vaccine after Limited Passages in Pigs
title_sort phenotypic and genetic evolutions of a porcine reproductive and respiratory syndrome modified live vaccine after limited passages in pigs
publisher MDPI AG
series Vaccines
issn 2076-393X
publishDate 2021-04-01
description Modified live vaccines (MLVs) against the porcine reproductive and respiratory syndrome virus (PRRSV) have been regularly associated with safety issues, such as reversion to virulence. In order to characterize the phenotypic and genetic evolution of the PRRSV-1 DV strain from the Porcilis<sup>®</sup> PRRS MLV after limited passages in pigs, three in vivo experiments were performed. Trial#1 aimed (i) at studying transmission of the vaccine strain from vaccinated to unvaccinated contact pigs. Trial#2 and Trial#3 were designed (ii) to assess the reproducibility of Trial#1, using another vaccine batch, and (iii) to compare the virulence levels of two DV strains isolated from vaccinated (passage one) and diseased contact pigs (passage two) from Trial#1. DV strain isolates from vaccinated and contact pigs from Trial#1 and Trial#2 were submitted to Next-Generation Sequencing (NGS) full-genome sequencing. All contact animals from Trial#1 were infected and showed significantly increased viremia compared to vaccinated pigs, whereas no such change was observed during Trial#2. In Trial#3, viremia and transmission were higher for inoculated pigs with passage two of the DV strain, compared with passage one. In this study, we showed that the re-adaptation of the DV strain to pigs is associated with faster replication and increased transmission of the vaccine strain. Punctually, a decrease of attenuation of the DV vaccine strain associated with clinical signs and increased viremia may occur after limited passages in pigs. Furthermore, we identified three mutations linked to pig re-adaptation and five other mutations as potential virulence determinants.
topic PRRS virus
modified live vaccine
attenuation
variants
mutation
url https://www.mdpi.com/2076-393X/9/4/392
work_keys_str_mv AT julieeclercy phenotypicandgeneticevolutionsofaporcinereproductiveandrespiratorysyndromemodifiedlivevaccineafterlimitedpassagesinpigs
AT patriciarenson phenotypicandgeneticevolutionsofaporcinereproductiveandrespiratorysyndromemodifiedlivevaccineafterlimitedpassagesinpigs
AT edouardhirchaud phenotypicandgeneticevolutionsofaporcinereproductiveandrespiratorysyndromemodifiedlivevaccineafterlimitedpassagesinpigs
AT mathieuandraud phenotypicandgeneticevolutionsofaporcinereproductiveandrespiratorysyndromemodifiedlivevaccineafterlimitedpassagesinpigs
AT veroniquebeven phenotypicandgeneticevolutionsofaporcinereproductiveandrespiratorysyndromemodifiedlivevaccineafterlimitedpassagesinpigs
AT fredericpaboeuf phenotypicandgeneticevolutionsofaporcinereproductiveandrespiratorysyndromemodifiedlivevaccineafterlimitedpassagesinpigs
AT nicolasrose phenotypicandgeneticevolutionsofaporcinereproductiveandrespiratorysyndromemodifiedlivevaccineafterlimitedpassagesinpigs
AT yannickblanchard phenotypicandgeneticevolutionsofaporcinereproductiveandrespiratorysyndromemodifiedlivevaccineafterlimitedpassagesinpigs
AT olivierbourry phenotypicandgeneticevolutionsofaporcinereproductiveandrespiratorysyndromemodifiedlivevaccineafterlimitedpassagesinpigs
_version_ 1721524199396212736